Jay A. Markwalder

1.4k total citations
18 papers, 897 citations indexed

About

Jay A. Markwalder is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jay A. Markwalder has authored 18 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Jay A. Markwalder's work include Microtubule and mitosis dynamics (4 papers), HIV/AIDS drug development and treatment (4 papers) and Advanced Breast Cancer Therapies (3 papers). Jay A. Markwalder is often cited by papers focused on Microtubule and mitosis dynamics (4 papers), HIV/AIDS drug development and treatment (4 papers) and Advanced Breast Cancer Therapies (3 papers). Jay A. Markwalder collaborates with scholars based in United States, Germany and India. Jay A. Markwalder's co-authors include Steven P. Seitz, Benjamin Schwartz, Yi Wang, Abdul Mutlib, David D. Christ, Yi Wang, Ross L. Stein, Sharon Jackson, Gregory A. Nemeth and William F. DeGrado and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jay A. Markwalder

18 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay A. Markwalder United States 13 467 285 146 123 103 18 897
Timothy E. Benson United States 20 778 1.7× 237 0.8× 187 1.3× 167 1.4× 148 1.4× 27 1.5k
Erica M. Pasini Netherlands 19 426 0.9× 186 0.7× 87 0.6× 143 1.2× 52 0.5× 33 1.5k
Joel Bard United States 14 768 1.6× 150 0.5× 110 0.8× 79 0.6× 161 1.6× 17 1.2k
James M. Fujitaki United States 18 585 1.3× 132 0.5× 238 1.6× 87 0.7× 94 0.9× 34 1.2k
Clarissa G. Jakob United States 17 594 1.3× 119 0.4× 74 0.5× 158 1.3× 238 2.3× 23 1.0k
Michel Garneau Canada 21 495 1.1× 212 0.7× 289 2.0× 113 0.9× 44 0.4× 57 1.3k
Thomas E. Spratt United States 27 1.2k 2.6× 166 0.6× 120 0.8× 173 1.4× 85 0.8× 62 1.7k
Yiqin Wu United States 19 1.3k 2.9× 302 1.1× 110 0.8× 222 1.8× 94 0.9× 37 1.6k
Wilhelm Stark Switzerland 13 642 1.4× 142 0.5× 45 0.3× 131 1.1× 77 0.7× 15 910
William F. Huffman United States 21 717 1.5× 569 2.0× 185 1.3× 125 1.0× 41 0.4× 67 1.4k

Countries citing papers authored by Jay A. Markwalder

Since Specialization
Citations

This map shows the geographic impact of Jay A. Markwalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay A. Markwalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay A. Markwalder more than expected).

Fields of papers citing papers by Jay A. Markwalder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay A. Markwalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay A. Markwalder. The network helps show where Jay A. Markwalder may publish in the future.

Co-authorship network of co-authors of Jay A. Markwalder

This figure shows the co-authorship network connecting the top 25 collaborators of Jay A. Markwalder. A scholar is included among the top collaborators of Jay A. Markwalder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay A. Markwalder. Jay A. Markwalder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Williams, David, Jay A. Markwalder, Aaron Balog, et al.. (2018). Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(4). 732–736. 15 indexed citations
2.
Markwalder, Jay A., Steven P. Seitz, Yuval Blat, et al.. (2016). Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(3). 582–585. 23 indexed citations
3.
Ross‐Macdonald, Petra, Heshani de Silva, Qi Guo, et al.. (2008). Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Molecular Cancer Therapeutics. 7(11). 3490–3498. 102 indexed citations
4.
Rossi, Karen A., Jay A. Markwalder, Steven P. Seitz, et al.. (2005). Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors. Journal of Computer-Aided Molecular Design. 19(2). 111–122. 10 indexed citations
5.
Yue, Eddy W., C. Anne Higley, Jay A. Markwalder, et al.. (2003). Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3. Bioorganic & Medicinal Chemistry Letters. 14(2). 343–346. 30 indexed citations
6.
Schwartz, Benjamin, Jay A. Markwalder, Steven P. Seitz, Yi Wang, & Ross L. Stein. (2002). A Kinetic Characterization of the Glycosyltransferase Activity of Eschericia coli PBP1b and Development of a Continuous Fluorescence Assay. Biochemistry. 41(41). 12552–12561. 100 indexed citations
7.
Barbosa, Maria D.F.S., Jay A. Markwalder, J.A.N. Mills, et al.. (2002). Regulated Expression of the Escherichia coli lepB Gene as a Tool for Cellular Testing of Antimicrobial Compounds That Inhibit Signal Peptidase I In Vitro. Antimicrobial Agents and Chemotherapy. 46(11). 3549–3554. 16 indexed citations
8.
Markwalder, Jay A., David D. Christ, Abdul Mutlib, et al.. (2001). Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz. Bioorganic & Medicinal Chemistry Letters. 11(5). 619–622. 12 indexed citations
9.
Carini, David J., Robert F. Kaltenbach, Jie Liu, et al.. (2001). Identification of selective inhibitors of cyclin dependent kinase 4. Bioorganic & Medicinal Chemistry Letters. 11(16). 2209–2211. 37 indexed citations
10.
Schwartz, Benjamin, Jay A. Markwalder, & Yi Wang. (2001). Lipid II:  Total Synthesis of the Bacterial Cell Wall Precursor and Utilization as a Substrate for Glycosyltransfer and Transpeptidation by Penicillin Binding Protein (PBP) 1b of Eschericia coli. Journal of the American Chemical Society. 123(47). 11638–11643. 112 indexed citations
11.
Corbett, Jeffrey W., Jay A. Markwalder, Beverly C. Cordova, et al.. (2001). 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(2). 211–214. 10 indexed citations
12.
Mutlib, Abdul, Ronald J. Gerson, Paul C. Meunier, et al.. (2000). The Species-Dependent Metabolism of Efavirenz Produces a Nephrotoxic Glutathione Conjugate in Rats. Toxicology and Applied Pharmacology. 169(1). 102–113. 62 indexed citations
13.
Patel, Mona, Robert J. McHugh, Jay A. Markwalder, et al.. (1999). Synthesis and evaluation of analogs of Efavirenz (SUSTIVATM) as HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(19). 2805–2810. 65 indexed citations
14.
15.
Markwalder, Jay A., Richard S. Pottorf, & Steven P. Seitz. (1997). One-Pot Conversion of α-Thioureido Esters to Imidazol-2-ones and Imidazole-2-thiones. Synlett. 1997(Sup. I). 521–522. 12 indexed citations
16.
Jackson, Sharon, William F. DeGrado, Anil Kumar Dwivedi, et al.. (1994). Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIa. Journal of the American Chemical Society. 116(8). 3220–3230. 140 indexed citations
17.
Bach, A., Jay A. Markwalder, & William C. Ripka. (1991). Synthesis and NMR conformational analysis of a β‐turn mimic incorporated into gramicidin S. International journal of peptide & protein research. 38(4). 314–323. 31 indexed citations
18.
Marshall, James A. & Jay A. Markwalder. (1988). Remote double stereodiffrentiation in macrocylizations of α-alkoxyallylstannanes. Tetrahedron Letters. 29(38). 4811–4814. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy E. Benson Breakdown of academic impact, for papers by Erica M. Pasini Breakdown of academic impact, for papers by Joel Bard Breakdown of academic impact, for papers by James M. Fujitaki Breakdown of academic impact, for papers by Clarissa G. Jakob Breakdown of academic impact, for papers by Michel Garneau Breakdown of academic impact, for papers by Thomas E. Spratt Breakdown of academic impact, for papers by Yiqin Wu Breakdown of academic impact, for papers by Wilhelm Stark Breakdown of academic impact, for papers by William F. Huffman
Rankless by CCL
2026